0 items USD 0.00Search
Your search for "global markets direct inflammation pipeline review h1 2014" gave back 48391 results.
The global Ocular Inflammation Treatment market size was valued at US$ million in 2023. With growing demand in downstream market, the Ocular...
Catalog:
LPI
March 2024
Price: USD 3,660.00
Important bispecific antibody targets are basically in clinical practice, and many momentous bispecific antibodies will be born in the future. The...
Catalog:
AEI
June 2021
Price: USD 3,000.00
Eye inflammations or uveitis are becoming a common problem for people across global geographies. New drugs are being discovered to treat ocular...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The drugs are classified as High Potent if its Occupational Exposure Limit (OELs) ≤ 10µg/m3.The HPAPI global market is progressively increasing in...
Catalog:
IQ4I
November 2017
Price: USD 4,950.00
The global H1 Receptor Antagonist market size is projected to grow from US$ 33950 million in 2022 to US$ 58130 million in 2029; it is expected to...
Catalog:
LPI
July 2023
Price: USD 3,660.00
Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. Humira...
Catalog:
LPI
January 2023
Price: USD 3,660.00
The global H1 Receptor Antagonist market size was valued at USD 35700 million in 2022 and is forecast to a readjusted size of USD 58730 million by...
Catalog:
GIR
August 2023
Price: USD 3,480.00
Global antirheumatics market is expected to grow in near future as aging and growing population, rising income levels, and emerging medical...
Catalog:
NAVADHI
June 2019
Price: USD 2,000.00
Anti-inflammatory peptides also known as antiflammins inhibit inflammation of a mammal\'s skin, lacerations of the musculature, mucous membranes...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The “Eyelid Inflammation Drug Industry Forecast” looks at past sales and reviews total world Eyelid Inflammation Drug sales in 2022, providing a...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Retina is a layer of nerve tissue lining the back of the eye. Retina receives light and convert it into neural signals, and send these signals to the...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Innovation and Clinical Trial Tracking Factbook 2017: An Assessment of the Pharmaceutical Pipeline Summary GBI Research’s latest report, “Innovation...
CBR Pharma Insights
May 2017
Price: USD 2,995.00
The global Humira market size was valued at US$ 16700 million in 2023. With growing demand in downstream market, the Humira is forecast to a...
Catalog:
LPI
January 2024
Price: USD 3,660.00
Acute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. Humira...
Catalog:
GIR
April 2023
Price: USD 3,480.00
